These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2670305)

  • 1. The effects of bay-region methyl substitution on 6-nitrochrysene mutagenicity in Salmonella typhimurium and tumorigenicity in newborn mice.
    el-Bayoumy K; Shiue GH; Amin S; Hecht SS
    Carcinogenesis; 1989 Sep; 10(9):1685-9. PubMed ID: 2670305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity, metabolism and DNA adduct formation of 6-nitrochrysene in Salmonella typhimurium.
    el-Bayoumy K; Delclos KB; Heflich RH; Walker R; Shiue GH; Hecht SS
    Mutagenesis; 1989 May; 4(3):235-40. PubMed ID: 2659942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative tumorigenicity of 6-nitrochrysene and its metabolites in newborn mice.
    el-Bayoumy K; Shiue GH; Hecht SS
    Carcinogenesis; 1989 Feb; 10(2):369-72. PubMed ID: 2912588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative tumorigenicity of nitrochrysene isomers in newborn mice.
    el-Bayoumy K; Desai D; Upadhyaya P; Amin S; Hecht SS
    Carcinogenesis; 1992 Dec; 13(12):2271-5. PubMed ID: 1473233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing effect of a bay region methyl group on tumorigenicity in newborn mice and mouse skin of enantiomeric bay region diol epoxides formed stereoselectively from methylchrysenes in mouse epidermis.
    Hecht SS; Amin S; Huie K; Melikian AA; Harvey RG
    Cancer Res; 1987 Oct; 47(20):5310-5. PubMed ID: 3652037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of trans-1,2-dihydro-1,2-dihydroxy-6-nitrochrysene as a major mutagenic metabolite of 6-nitrochrysene.
    El-Bayoumy K; Hecht SS
    Cancer Res; 1984 Aug; 44(8):3408-13. PubMed ID: 6378368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 6-methylchrysene-1,2-diol-3,4-epoxides and comparison of their mutagenicity to 5-methylchrysene-1,2-diol-3,4-epoxides.
    Amin S; Huie K; Hecht SS; Harvey RG
    Carcinogenesis; 1986 Dec; 7(12):2067-70. PubMed ID: 3779900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity with DNA bases and mutagenicity toward Salmonella typhimurium of methylchrysene diol epoxide enantiomers.
    Melikian AA; Amin S; Huie K; Hecht SS; Harvey RG
    Cancer Res; 1988 Apr; 48(7):1781-7. PubMed ID: 3258179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and tumor-initiating activities of dimethylchrysenes.
    Amin S; Balanikas G; Huie K; Hecht SS
    Chem Res Toxicol; 1988; 1(6):349-55. PubMed ID: 2979752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimethylchrysene diol epoxides: mutagenicity in Salmonella typhimurium, tumorigenicity in newborn mice, and reactivity with deoxyadenosine in DNA.
    Misra B; Amin S; Hecht SS
    Chem Res Toxicol; 1992; 5(2):248-54. PubMed ID: 1643255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative metabolic activation in mouse skin of the weak carcinogen 6-methylchrysene and the strong carcinogen 5-methylchrysene.
    Amin S; Huie K; Melikian AA; Leszczynska JM; Hecht SS
    Cancer Res; 1985 Dec; 45(12 Pt 1):6406-42. PubMed ID: 4063989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of the optical isomers of the diastereomeric bay-region chrysene 1,3-diol-3,4-epoxides in bacterial and mammalian cells.
    Wood AW; Chang RL; Levin W; Yagi H; Tada M; Vyas KP; Jerina DM; Conney AH
    Cancer Res; 1982 Aug; 42(8):2972-6. PubMed ID: 7046912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity and tumorigenicity of the four enantiopure bay-region 3,4-diol-1,2-epoxide isomers of dibenz[a,h]anthracene.
    Chang RL; Wood AW; Huang MT; Xie JG; Cui XX; Reuhl KR; Boyd DR; Lin Y; Shih WJ; Balani SK; Yagi H; Jerina DM; Conney AH
    Carcinogenesis; 2013 Sep; 34(9):2184-91. PubMed ID: 23671133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 6-nitro substitution on 5-methylchrysene tumorigenicity, mutagenicity and metabolism.
    el-Bayoumy K; Amin S; Hecht SS
    Carcinogenesis; 1986 Apr; 7(4):673-6. PubMed ID: 3509952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and mutagenicity of 5-alkyl-substituted chrysene-1,2-diol-3,4-epoxides.
    Amin S; Huie K; Balanikas G; Hecht SS
    Carcinogenesis; 1988 Dec; 9(12):2305-8. PubMed ID: 3191576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative tumorigenicity in newborn mice of chrysene- and 5-alkylchrysene-1,2-diol-3,4-epoxides.
    Amin S; Misra B; Braley J; Hecht SS
    Cancer Lett; 1991 Jun; 58(1-2):115-8. PubMed ID: 2049777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative tumor initiating activities of cyclopentano and methyl derivatives of 5-methylchrysene and chrysene.
    Amin S; Hecht SS; Di Raddo P; Harvey RG
    Cancer Lett; 1990 May; 51(1):17-20. PubMed ID: 2337893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly tumorigenic bay-region diol epoxides from the weak carcinogen benzo[c]phenanthrene.
    Jerina DM; Sayer JM; Yagi H; Croisy-Delcey M; Ittah Y; Thakker DR; Wood AW; Chang RL; Levin W; Conney AH
    Adv Exp Med Biol; 1981; 136 Pt A():501-23. PubMed ID: 7046379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity and tumorigenicity of dihydrodiols, diol epoxides, and other derivatives of benzo(f)quinoline and benzo(h)quinoline.
    Kumar S; Sikka HC; Dubey SK; Czech A; Geddie N; Wang CX; LaVoie EJ
    Cancer Res; 1989 Jan; 49(1):20-4. PubMed ID: 2908847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.